Innovation, Health, Humanity
Our pioneering technology aims to address significant gaps in genomic research, diagnostics, and therapeutics, particularly by identifying the areas of the genome that are unseen today.
At the heart of our company's differentiation is our pioneering direct optical long-read sequencing approach. This revolutionary method combines cutting-edge nanofluidic processes with optics to unearth an unprecedented level of genomic information.
CEO
Emily Milsovic
FOUNDER & CSO
Steve Brueck
BOARD OF DIRECTORS
Todd Dickinson
VP of Product Development
Matt Springer
HEAD OF EPIGENETICS
Dr. Ben Delatte
BOARD OF DIRECTORS
David Blivin
BOARD OF DIRECTORS
Waneta Tuttle
BOARD OF DIRECTORS
Scott Goldman
Scientific Advisory Board
Charles Cantor, PhD
Lead Scientific Advisor
Jeremy Edwards, PhD
Professor of Molecular Genetics & Microbiology, UNIVERSITY OF NEW MEXICO
John Finan, MBA
Life sciences commercial operations leader,
BAKER TILLY HEALTHCARE CONSULTING
Edgar Mendoza, PhD
CEO, REDONDO OPTICS, INC.